Antimalarial medication "Lariam". Lariam is fairly expensive at around 3 € per tablet (pricing of the year 2000). A dose of 15–25 mg/kg is recommended, depending on the prevalence of mefloquine resistance. The increased dosage is associated with a much greater level of intolerance, most noticeably in young children; with the drug inducing vomiting and esophagitis. It was not recommended for use during the first trimester, although considered safe during the second and third trimesters; nevertheless, in October 2011, the Centers for Disease Control and Prevention (CDC) changed its recommendation and approved use of Mefloquine for both prophylaxis and treatment of malaria
Association for the Treatment of Sexual Abusers of sexual abuse through effective treatment and management of sex offenders. It has approximately 3,000 members from 26 countries, with chapters throughout the United States and in Utrecht, Netherlands. Members include researchers, treatment providers, corrections officials, attorneys, law enforcement officers, and students. ATSA hosts the world's largest annual conference and leading educational venue for individuals working on issues related to the research, treatment, and management of sexual abuse. Conference locations vary each year. The official journal of ATSA is "Sexual Abuse", produced eight times a year. According to the Institute for Scientific Information, the peer-reviewed journal's 2016 impact factor was